KF
JAZZ icon

Krilogy Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Krilogy Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Buy
+2,064
New +$452K 0.01% 635
2018
Q4 		– Sell
-585
Closed -$98K – 410
2018
Q3 		$98K Buy
+585
New +$101K 0.02% 223
2018
Q2 		– Sell
-975
Closed -$147K – 396
2018
Q1 		$147K Sell
975
-50
-5% -$7.33K 0.04% 181
2017
Q4 		$138K Hold
1,025
– – 0.03% 183
2017
Q3 		$150K Sell
1,025
-575
-36% -$87K 0.04% 195
2017
Q2 		$249K Sell
1,600
-1,300
-45% -$199K 0.07% 121
2017
Q1 		$316K Hold
2,900
– – 0.1% 93
2016
Q4 		$316K Sell
2,900
-250
-8% -$27.8K 0.1% 93
2016
Q3 		$383K Sell
3,150
-100
-3% -$13.5K 0.12% 82
2016
Q2 		$459K Sell
3,250
-100
-3% -$14.7K 0.16% 73
2016
Q1 		$437K Sell
3,350
-500
-13% -$62.2K 0.18% 58
2015
Q4 		$541K Sell
3,850
-50
-1% -$6.93K 0.5% 29
2015
Q3 		$518K Buy
+3,900
New +$672K 0.25% 50

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Krilogy Financial's JAZZ Position: Q2 2026 in Review

Krilogy Financial opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,064 shares worth $497K. The stake represents 0.01% of the portfolio and ranks #635 among its holdings. This is a return to the name: Krilogy Financial previously reported a position in JAZZ as recently as Q3 2018.

Krilogy Financial first reported a position in JAZZ in Q3 2015 and has held it in 13 quarters since. The position peaked at $541K in Q4 2015. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Krilogy Financial held 2,064 shares of Jazz Pharmaceuticals worth $497K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Krilogy Financial position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Krilogy Financial's portfolio in Q2 2026, its #635 holding.
  • Krilogy Financial first reported a position in Jazz Pharmaceuticals in Q3 2015 and has held it in 13 quarters since.
  • Krilogy Financial's Jazz Pharmaceuticals position peaked at $541K in Q4 2015.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.